DEBORAH KNOBELMAN
CIK 1931509 · President & Interim CEO · last filed 2025-06-20
DEBORAH KNOBELMAN is a President & Interim CEO who has filed 6 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for KRON, was dated Jun 20, 2025. Across all open-market trades the lifetime net is −$21.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $125.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$125.8K
2
6
-$21.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Kronos Bio, Inc. (KRON) Delisted | President & Interim CEO | 0 | $0.88 | $0 | -$21.6K | 3 | 2025-06-20 |
| SNTI | Chief Financial Officer | 131,000 | $0.96 | $125.8K | $0 | 3 | 2024-02-02 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-20 | Kronos Bio, Inc. (KRON) Delisted | Mixed | −139,422 | -$79.5K | EDGAR |
| 2025-06-06 | Kronos Bio, Inc. (KRON) Delisted | Sell (S) | −24,838 | -$21.6K | EDGAR |
| 2024-06-04 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | +164,260 | $0 | EDGAR |
| 2024-02-02 | SNTI | Grant (A) | +101,000 | $0 | EDGAR |
| 2023-02-02 | SNTI | Grant (A) | — | $0 | EDGAR |
| 2022-10-04 | SNTI | Grant (A) | +30,000 | $0 | EDGAR |